Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CytoDyn Inc.CYDY · Entity 5856 | Chief Scientific Officer | October 16, 2020 | October 21, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CytoDyn Inc.
Report date October 16, 2020 · Filed October 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 200,000 |
Reported balance
After 2020-10-16 transaction · row 1
1 source rowRow 1 · 2020-10-16 · Grant · Acquired 200,000 · Balance 200,000 F1: Represents restricted stock units vesting annually over 3 years in equal amounts beginning October 16, 2021. F2: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units vesting annually over 3 years in equal amounts beginning October 16, 2021.
F2: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2020 Filed Oct 21, 2020 00:56 UTC | CytoDyn Inc. CYDY · Entity 5856 | GrantCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001807094-20-000023 · primary_doc.xml · nonDerivative · entry 1 Rahman Mahboob U · CIK 0001828905 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · shares: Represents restricted stock units vesting annually over 3 years in equal amounts beginning October 16, 2021. F2 · price: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.